SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-286815
Filing Date
2021-09-29
Accepted
2021-09-29 16:42:56
Documents
15
Period of Report
2021-09-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d234534d8k.htm   iXBRL 8-K 27961
2 EX-10.1 d234534dex101.htm EX-10.1 43930
3 EX-99.1 d234534dex991.htm EX-99.1 21449
7 GRAPHIC g234534snap0001.jpg GRAPHIC 5316
  Complete submission text file 0001193125-21-286815.txt   246197

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA mirm-20210928.xsd EX-101.SCH 2889
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20210928_lab.xml EX-101.LAB 18888
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20210928_pre.xml EX-101.PRE 11858
8 EXTRACTED XBRL INSTANCE DOCUMENT d234534d8k_htm.xml XML 3478
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 211292247
SIC: 2834 Pharmaceutical Preparations